Reveals malaria's impact on the liver in humans, highlighting implications for treatment and prevention.
Malaria, an infectious disease caused by Plasmodium parasites, is a significant global health issue, particularly in tropical and subtropical regions. Understanding the development of malaria in the human body and its effects on vital organs like the liver is crucial for effective control and prevention. The liver is a key site for the Plasmodium parasite′s growth and multiplication, leading to various liver‐related symptoms such as liver malfunction, skin and eye yellowing, and an enlarged liver. Severe and cerebral malaria are caused by intricate processes such as cytoadherence, sequestration, inflammation, and endothelial dysfunction. The liver facilitates immune regulation and tissue repair, preventing cerebral complications and directing focused therapeutic interventions. Understanding the complex connection between malaria and the liver is essential for developing new treatments and vaccines. The molecular pathways causing liver damage and immunological responses during infection provide new treatments and vaccine opportunities. Strategies to minimize liver damage associated with malaria include early detection, immediate treatment, and effective efforts to prevent disease‐carrying vectors. This approach can significantly reduce malaria′s impact and improve patient outcomes. Therefore, comprehensive research is crucial to comprehend malaria pathogenesis and the liver′s role in the disease′s progression.
No takes yet. Share an insight, caveat, or question.
Mandal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: